Hollings Renton, Director at CEPHEID (CPHD), sold 12,500 shares at $46.32 ($573K) on 2014-10-20, disclosed to the SEC on 2014-10-22.
Open-market sale of $573k CPHD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.83 | 11,900 | $545K | 95.2% |
| 2 | $46.32 | 600 | $28K | 4.8% |
| Total | $45.85 avg | 12,500 | $573K | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |